Healio
›
Hepatology
›
News
-
Meeting News Coverage
-
-
May 2, 2013
-
Obese patients who lose weight via lifestyle intervention or bariatric surgery experienced improvement to histological and metabolic elements of...More
»
-
Meeting News Coverage
-
-
May 1, 2013
-
Patients with cirrhosis treated with beta-blockers experienced improved intestinal permeability and reduced bacterial translocation, reducing the risk for...More
»
-
Meeting News Coverage
-
-
May 1, 2013
-
Simeprevir improves rates of sustained virologic response and may allow for a 24-week treatment duration when added to interferon-based therapy for...More
»
-
-
-
April 30, 2013
-
The FDA has determined that tolvaptan should not be used for longer than 30 days or in patients with underlying liver disease because it may cause liver...More
»
-
Meeting News Coverage
-
-
April 30, 2013
-
Heavy alcohol consumption and obesity increase the risk for liver-related morbidity and death, while metabolic risk factors also elevate the risk for...More
»
-
Meeting News Coverage
-
-
April 30, 2013
-
Treatment-naive patients with chronic hepatitis C experienced high rates of sustained virologic response from a combination of three direct-acting...More
»
-
Meeting News Coverage
-
-
April 29, 2013
-
Patients with cirrhosis were less likely to develop overt hepatic encephalopathy when taking probiotics than controls in a study presented at the...More
»
-
Meeting News Coverage
-
-
April 29, 2013
-
The addition of faldaprevir to pegylated interferon/ribavirin therapy significantly improved rates of sustained virologic response and allowed for shorter...More
»
-
Meeting News Coverage
-
-
April 26, 2013
-
Liver transplant recipients who received everolimus-based immunosuppression with reduced tacrolimus experienced similar results to those treated with...More
»
-
Meeting News Coverage
-
-
April 26, 2013
-
Nearly all patients with chronic hepatitis C treated with an interferon-free drug regimen for 12 or 24 weeks experienced sustained virologic response in a...More
»